General Information of This Antigen
Antigen ID
TAR0EBTXG
Antigen Name
B-lymphocyte antigen CD19 (CD19)
Gene Name
CD19
Gene ID
930
Synonym
B-lymphocyte surface antigen B4; Differentiation antigen CD19;T-cell surface antigen Leu-12;CD_antigen=CD19
Sequence
MPPPRLLFFLLFLTPMEVRPEEPLVVKVEEGDNAVLQCLKGTSDGPTQQLTWSRESPLKP
FLKLSLGLPGLGIHMRPLAIWLFIFNVSQQMGGFYLCQPGPPSEKAWQPGWTVNVEGSGE
LFRWNVSDLGGLGCGLKNRSSEGPSSPSGKLMSPKLYVWAKDRPEIWEGEPPCLPPRDSL
NQSLSQDLTMAPGSTLWLSCGVPPDSVSRGPLSWTHVHPKGPKSLLSLELKDDRPARDMW
VMETGLLLPRATAQDAGKYYCHRGNLTMSFHLEITARPVLWHWLLRTGGWKVSAVTLAYL
IFCLCSLVGILHLQRALVLRRKRKRMTDPTRRFFKVTPPPGSGPQNQYGNVLSLPTPTSG
LGRAQRWAAGLGGTAPSYGNPSSDVQADGALGSRSPPGVGPEEEEGEGYEEPDSEEDSEF
YENDSNLGQDQLSQDGSGYENPEDEPLGPEDEDSFSNAESYENEDEELTQPVARTMDFLS
PHGSAWDPSREATSLGSQSYEDMRGILYAAPQLRSIRGQPGPNHEEDADSYENMDNPDGP
DPAWGGGGRMGTWSTR

    Click to Show/Hide
Function
Functions as coreceptor for the B-cell antigen receptor complex (BCR) on B-lymphocytes. Decreases the threshold for activation of downstream signaling pathways and for triggering B-cell responses to antigens. Activates signaling pathways that lead to the activation of phosphatidylinositol 3-kinase and the mobilization of intracellular Ca(2+) stores. Is not required for early steps during B cell differentiation in the blood marrow. Required for normal differentiation of B-1 cells. Required for normal B cell differentiation and proliferation in response to antigen challenges. Required for normal levels of serum immunoglobulins, and for production of high-affinity antibodies in response to antigen challenge.

    Click to Show/Hide
Uniprot Entry
CD19_HUMAN
HGNC ID
HGNC:1633
KEGG ID
hsa:930
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
ADC Info ADC Name Payload Target Linker Ref
AFM-11-2i
Monomethyl auristatin F
Microtubule (MT)
AFM-11-2i linker
[1]
AFM-11-4i
Monomethyl auristatin F
Microtubule (MT)
AFM-11-4i linker
[1]
AFM-11-3i
Monomethyl auristatin F
Microtubule (MT)
AFM-11-3i linker
[1]
AFM-11-6e
Monomethyl auristatin E
Microtubule (MT)
AFM-11-6e linker
[1]
AFM-11-amanitin
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
AFM-11-amanitin linker
[1]
ADC Info ADC Name Payload Target Linker Ref
AFM-12-2i
Monomethyl auristatin F
Microtubule (MT)
AFM-12-2i linker
[1]
AFM-12-4i
Monomethyl auristatin F
Microtubule (MT)
AFM-12-4i linker
[1]
AFM-12-3i
Monomethyl auristatin F
Microtubule (MT)
AFM-12-3i linker
[1]
AFM-12-6e
Monomethyl auristatin E
Microtubule (MT)
AFM-12-6e linker
[1]
AFM-12-amanitin
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
AFM-12-amanitin linker
[1]
Anti-CD19 ABBV319 IgG1 mAb
ADC Info ADC Name Payload Target Linker Ref
ABBV-319
Proprietary GRM agonist
Glucocorticoid receptor (NR3C1)
Formyl-Ala-Ala
[2]
Anti-CD19 mAb B4
ADC Info ADC Name Payload Target Linker Ref
B4-SPP-DC44
DC44
Human Deoxyribonucleic acid (hDNA)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
[3]
B4-SMCC-DC4
Phosphate prodrugs 40 (DC4)
Human Deoxyribonucleic acid (hDNA)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
[3]
B4-SPP-DC4
Phosphate prodrugs 40 (DC4)
Human Deoxyribonucleic acid (hDNA)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
[3]
B4-SPP-DC1
DC1
Human Deoxyribonucleic acid (hDNA)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
[3]
Anti-CD19 mAb DI-B4
ADC Info ADC Name Payload Target Linker Ref
LCB14-0648
Monomethyl auristatin F
Microtubule (MT)
LCB14-0648 linker
[1]
LCB14-0663
Monomethyl auristatin F
Microtubule (MT)
LCB14-0663 linker
[1]
LCB14-0664
Monomethyl auristatin F
Microtubule (MT)
LCB14-0664 linker
[1]
LCB14-6e
Monomethyl auristatin E
Microtubule (MT)
LCB14-6e linker
[1]
WO2017089895A1 ADC67
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC67 linker
[4]
WO2017089895A1 ADC68
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC68 linker
[4]
WO2017089895A1 ADC69
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC69 linker
[4]
LCB14-alpha-amanitin
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
LCB14-alpha-amanitin linker
[1]
WO2017089890A1 ADC67
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC67 linker
[5]
WO2017089890A1 ADC68
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC68 linker
[5]
WO2017089890A1 ADC69
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC69 linker
[5]
Anti-CD19 mAb hA19
ADC Info ADC Name Payload Target Linker Ref
HA19-SN38 antibody-drug conjugate
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
CL2A
[6]
Anti-CD19 mAb hBU12
ADC Info ADC Name Payload Target Linker Ref
hBU12-mc-MMAF
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
[7]
Anti-CD19 mAb hBU12ec
ADC Info ADC Name Payload Target Linker Ref
SGN-CD19B
SGD-1882
Human Deoxyribonucleic acid (hDNA)
Mc-Val-Ala
[8]
ADC Info ADC Name Payload Target Linker Ref
cHD37-2i
Monomethyl auristatin F
Microtubule (MT)
cHD37-2i linker
[1]
cHD37-4i
Monomethyl auristatin F
Microtubule (MT)
cHD37-4i linker
[1]
cHD37-3i
Monomethyl auristatin F
Microtubule (MT)
cHD37-3i linker
[1]
cHD37-6e
Monomethyl auristatin E
Microtubule (MT)
cHD37-6e linker
[1]
cHD37-amanitin
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
cHD37-amanitin linker
[1]
Coltuximab
ADC Info ADC Name Payload Target Linker Ref
Coltuximab ravtansine
Mertansine DM4
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
[9]
Denintuzumab
ADC Info ADC Name Payload Target Linker Ref
Denintuzumab-2i
Monomethyl auristatin F
Microtubule (MT)
Denintuzumab-2i linker
[1]
Denintuzumab-4i
Monomethyl auristatin F
Microtubule (MT)
Denintuzumab-4i linker
[1]
Denintuzumab-3i
Monomethyl auristatin F
Microtubule (MT)
Denintuzumab-3i linker
[1]
Denintuzumab-6e
Monomethyl auristatin E
Microtubule (MT)
Denintuzumab-6e linker
[1]
Denintuzumab-amanitin
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Denintuzumab-amanitin linker
[1]
hBU12-mcMMAF
Monomethyl auristatin F
Microtubule (MT)
Maleimido-caproyl
[10]
hBU12-MC-vc-PABC-MMAE
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
[10]
hBU12-MC-vc-PABC-MMAF DAR4
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
[10]
hBU12-1 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Phe-Dpr-MA
[10]
hBU12-1 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Phe-Dpr-MA
[10]
hBU12-2 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Phe-Glu-Dpr-MA
[10]
hBU12-2 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Phe-Glu-Dpr-MA
[10]
hBU12-3 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Thr-Dpr-MA
[10]
hBU12-3 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Thr-Dpr-MA
[10]
hBU12-4 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Thr-Glu-Dpr-MA
[10]
hBU12-4 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Thr-Glu-Dpr-MA
[10]
hBU12-5 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Phe-Glu-Dpr-MDpr
[10]
hBU12-5 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Phe-Glu-Dpr-MDpr
[10]
hBU12-6 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Thr-Glu-Dpr-MDpr
[10]
hBU12-6 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Thr-Glu-Dpr-MDpr
[10]
hBU12-7 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Thr-Glu-Lys-MDpr
[10]
hBU12-7 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Thr-Glu-Lys-MDpr
[10]
hBU12-8 MMAE
Monomethyl auristatin E
Microtubule (MT)
Thiazole-Glu-Lys-MDpr
[10]
hBU12-9 MMAE
Monomethyl auristatin E
Microtubule (MT)
Phe-Glu-EDA-MDpr
[10]
hBU12-10 MMAE
Monomethyl auristatin E
Microtubule (MT)
Thr-Glu-EDA-MDpr
[10]
hBU12-11 MMAE
Monomethyl auristatin E
Microtubule (MT)
Phe-Ile-EDA-MDpr
[10]
hBU12-12 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Thr-Ile-EDA-MDpr
[10]
hBU12-13 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Thiazole-Glu-EDA-MDpr
[10]
hBU12-14 MMAE
Monomethyl auristatin E
Microtubule (MT)
Asp-Ala-Lys-MDpr
[10]
hBU12-15 MMAE
Monomethyl auristatin E
Microtubule (MT)
Glu-Ala-Lys-MDpr
[10]
hBU12-16 MMAE
Monomethyl auristatin E
Microtubule (MT)
PhosphoThr-Ala-Lys-MDpr
[10]
hBU12-17 MMAE
Monomethyl auristatin E
Microtubule (MT)
Asn-AlaGlu-Dpr-MDpr
[10]
hBU12-18 MMAE
Monomethyl auristatin E
Microtubule (MT)
Glu-Ala-Glu-Dpr-MDpr
[10]
hBU12-19 MMAE
Monomethyl auristatin E
Microtubule (MT)
Asp-AlaGlu-Dpr-MDpr
[10]
hBU12-20 MMAE
Monomethyl auristatin E
Microtubule (MT)
Glu-Ala-Glu-Dpr-MDpr
[10]
hBU12-21 MMAE
Monomethyl auristatin E
Microtubule (MT)
hSer-Ala-Glu-Dpr-MDpr
[10]
hBU12-22 MMAE
Monomethyl auristatin E
Microtubule (MT)
ValoH-AlaGlu-Dpr-MDpr
[10]
hBU12-23 MMAE
Monomethyl auristatin E
Microtubule (MT)
PhosphoThr-Ala-Glu-Dpr-MDpr
[10]
hBU12-24 MMAE
Monomethyl auristatin E
Microtubule (MT)
Pyrazole-Glu-Dpr-MDpr
[10]
hBU12-25 MMAE
Monomethyl auristatin E
Microtubule (MT)
Triazole-Glu-Dpr-MDpr
[10]
hBU12-26 MMAE
Monomethyl auristatin E
Microtubule (MT)
Asn-Glu-Dpr-MDpr
[10]
hBU12-27 MMAE
Monomethyl auristatin E
Microtubule (MT)
Asp-Glu-Dpr-MDpr
[10]
hBU12-28 MMAE
Monomethyl auristatin E
Microtubule (MT)
Fur-Glu-Dpr-MDpr
[10]
hBU12-29 MMAE
Monomethyl auristatin E
Microtubule (MT)
ValOH-Glu-Dpr-MDpr
[10]
hBU12-30 MMAE
Monomethyl auristatin E
Microtubule (MT)
Ser-Glu-Dpr-MDpr
[10]
hBU12-31 MMAE
Monomethyl auristatin E
Microtubule (MT)
hSer-Glu-Dpr-MDpr
[10]
hBU12-32 MMAE
Monomethyl auristatin E
Microtubule (MT)
Thr-IleLeu-Dpr-MDpr
[10]
hBU12-33 MMAE
Monomethyl auristatin E
Microtubule (MT)
Phe-Ile-Leu-Dpr-MDpr
[10]
hBU12-34 MMAE
Monomethyl auristatin E
Microtubule (MT)
Glu-Phe-Leu-Dpr-MDpr
[10]
hBU12-35 MMAE
Monomethyl auristatin E
Microtubule (MT)
Thr-LeuPhe-Dpr-MDpr
[10]
hBU12-36 MMAE
Monomethyl auristatin E
Microtubule (MT)
Phe-Leu-Phe-Dpr-MDpr
[10]
hBU12-37 MMAE
Monomethyl auristatin E
Microtubule (MT)
Glu-Phe-Phe-Dpr-MDpr
[10]
hBU12-38 MMAE
Monomethyl auristatin E
Microtubule (MT)
Thr-LysAla-Dpr-MDpr
[10]
hBU12-39 MMAE
Monomethyl auristatin E
Microtubule (MT)
Thr-Lys-Dpr-MDpr
[10]
hBU12-1 MMAF
Monomethyl auristatin F
Microtubule (MT)
Phe-Dpr-MA
[10]
hBU12-2 MMAF
Monomethyl auristatin F
Microtubule (MT)
Phe-Glu-Dpr-MA
[10]
hBU12-3 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-Dpr-MA
[10]
hBU12-4 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-Glu-Dpr-MA
[10]
hBU12-5 MMAF
Monomethyl auristatin F
Microtubule (MT)
Phe-Glu-Dpr-MDpr
[10]
hBU12-6 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-Glu-Dpr-MDpr
[10]
hBU12-7 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-Glu-Lys-MDpr
[10]
hBU12-8 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thiazole-Glu-Lys-MDpr
[10]
hBU12-9 MMAF
Monomethyl auristatin F
Microtubule (MT)
Phe-Glu-EDA-MDpr
[10]
hBU12-10 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-Glu-EDA-MDpr
[10]
hBU12-11 MMAF
Monomethyl auristatin F
Microtubule (MT)
Phe-Ile-EDA-MDpr
[10]
hBU12-12 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-Ile-EDA-MDpr
[10]
hBU12-13 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thiazole-Glu-EDA-MDpr
[10]
hBU12-14 MMAF
Monomethyl auristatin F
Microtubule (MT)
Asp-Ala-Lys-MDpr
[10]
hBU12-15 MMAF
Monomethyl auristatin F
Microtubule (MT)
Glu-Ala-Lys-MDpr
[10]
hBU12-16 MMAF
Monomethyl auristatin F
Microtubule (MT)
PhosphoThr-Ala-Lys-MDpr
[10]
hBU12-17 MMAF
Monomethyl auristatin F
Microtubule (MT)
Asn-AlaGlu-Dpr-MDpr
[10]
hBU12-18 MMAF
Monomethyl auristatin F
Microtubule (MT)
Glu-Ala-Glu-Dpr-MDpr
[10]
hBU12-19 MMAF
Monomethyl auristatin F
Microtubule (MT)
Asp-AlaGlu-Dpr-MDpr
[10]
hBU12-20 MMAF
Monomethyl auristatin F
Microtubule (MT)
Glu-Ala-Glu-Dpr-MDpr
[10]
hBU12-21 MMAF
Monomethyl auristatin F
Microtubule (MT)
hSer-Ala-Glu-Dpr-MDpr
[10]
hBU12-22 MMAF
Monomethyl auristatin F
Microtubule (MT)
ValoH-AlaGlu-Dpr-MDpr
[10]
hBU12-23 MMAF
Monomethyl auristatin F
Microtubule (MT)
PhosphoThr-Ala-Glu-Dpr-MDpr
[10]
hBU12-24 MMAF
Monomethyl auristatin F
Microtubule (MT)
Pyrazole-Glu-Dpr-MDpr
[10]
hBU12-25 MMAF
Monomethyl auristatin F
Microtubule (MT)
Triazole-Glu-Dpr-MDpr
[10]
hBU12-26 MMAF
Monomethyl auristatin F
Microtubule (MT)
Asn-Glu-Dpr-MDpr
[10]
hBU12-27 MMAF
Monomethyl auristatin F
Microtubule (MT)
Asp-Glu-Dpr-MDpr
[10]
hBU12-28 MMAF
Monomethyl auristatin F
Microtubule (MT)
Fur-Glu-Dpr-MDpr
[10]
hBU12-29 MMAF
Monomethyl auristatin F
Microtubule (MT)
ValOH-Glu-Dpr-MDpr
[10]
hBU12-30 MMAF
Monomethyl auristatin F
Microtubule (MT)
Ser-Glu-Dpr-MDpr
[10]
hBU12-31 MMAF
Monomethyl auristatin F
Microtubule (MT)
hSer-Glu-Dpr-MDpr
[10]
hBU12-32 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-IleLeu-Dpr-MDpr
[10]
hBU12-33 MMAF
Monomethyl auristatin F
Microtubule (MT)
Phe-Ile-Leu-Dpr-MDpr
[10]
hBU12-34 MMAF
Monomethyl auristatin F
Microtubule (MT)
Glu-Phe-Leu-Dpr-MDpr
[10]
hBU12-35 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-LeuPhe-Dpr-MDpr
[10]
hBU12-36 MMAF
Monomethyl auristatin F
Microtubule (MT)
Phe-Leu-Phe-Dpr-MDpr
[10]
hBU12-37 MMAF
Monomethyl auristatin F
Microtubule (MT)
Glu-Phe-Phe-Dpr-MDpr
[10]
hBU12-38 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-LysAla-Dpr-MDpr
[10]
hBU12-39 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-Lys-Dpr-MDpr
[10]
hBU12-MC-vc-PABC-MMAF DAR8
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
[10]
hBU12-13 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Thiazole-Glu-EDA-MDpr
[10]
hBU12-12 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Thr-Ile-EDA-MDpr
[10]
hBU12-11 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Phe-Ile-EDA-MDpr
[10]
hBU12-17 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Asn-AlaGlu-Dpr-MDpr
[10]
hBU12-20 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Glu-Ala-Glu-Dpr-MDpr
[10]
hBU12-24 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Pyrazole-Glu-Dpr-MDpr
[10]
hBU12-29 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
ValOH-Glu-Dpr-MDpr
[10]
DI-B4-(LC)-GGGGGGG-CVIM
ADC Info ADC Name Payload Target Linker Ref
Anti-CD19(LC)-G7VIM-2i
Monomethyl auristatin F
Microtubule (MT)
Anti-CD19(LC)-G7VIM-2i linker
[1]
Anti-CD19(LC)-G7VIM-4i
Monomethyl auristatin F
Microtubule (MT)
Anti-CD19(LC)-G7VIM-4i linker
[1]
Anti-CD19(LC)-G7VIM-3i
Monomethyl auristatin F
Microtubule (MT)
Anti-CD19(LC)-G7VIM-3i linker
[1]
Anti-CD19(LC)-G7VIM-6e
Monomethyl auristatin E
Microtubule (MT)
Anti-CD19(LC)-G7VIM-6e linker
[1]
Anti-CD19(LC)-G7VIM-amanitin
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Anti-CD19(LC)-G7VIM-amanitin linker
[1]
ADC Info ADC Name Payload Target Linker Ref
GBR401-2i
Monomethyl auristatin F
Microtubule (MT)
GBR401-2i linker
[1]
GBR401-4i
Monomethyl auristatin F
Microtubule (MT)
GBR401-4i linker
[1]
GBR401-3i
Monomethyl auristatin F
Microtubule (MT)
GBR401-3i linker
[1]
GBR401-6e
Monomethyl auristatin E
Microtubule (MT)
GBR401-6e linker
[1]
GBR401-amanitin
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
GBR401-amanitin linker
[1]
Inebilizumab
ADC Info ADC Name Payload Target Linker Ref
Inebilizumab-2i
Monomethyl auristatin F
Microtubule (MT)
Inebilizumab-2i linker
[1]
Inebilizumab-4i
Monomethyl auristatin F
Microtubule (MT)
Inebilizumab-4i linker
[1]
Inebilizumab-3i
Monomethyl auristatin F
Microtubule (MT)
Inebilizumab-3i linker
[1]
Inebilizumab-6e
Monomethyl auristatin E
Microtubule (MT)
Inebilizumab-6e linker
[1]
Inebilizumab-amanitin
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Inebilizumab-amanitin linker
[1]
Loncastuximab
ADC Info ADC Name Payload Target Linker Ref
Loncastuximab tesirine
SG3199
Human Deoxyribonucleic acid (hDNA)
Mal-PEG8-Val-Ala-PABC
[11]
ADC Info ADC Name Payload Target Linker Ref
MDX-1342-2i
Monomethyl auristatin F
Microtubule (MT)
MDX-1342-2i linker
[1]
MDX-1342-4i
Monomethyl auristatin F
Microtubule (MT)
MDX-1342-4i linker
[1]
MDX-1342-3i
Monomethyl auristatin F
Microtubule (MT)
MDX-1342-3i linker
[1]
MDX-1342-6e
Monomethyl auristatin E
Microtubule (MT)
MDX-1342-6e linker
[1]
MDX-1342-amanitin
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
MDX-1342-amanitin linker
[1]
ADC Info ADC Name Payload Target Linker Ref
MDX-1435-2i
Monomethyl auristatin F
Microtubule (MT)
MDX-1435-2i linker
[1]
MDX-1435-4i
Monomethyl auristatin F
Microtubule (MT)
MDX-1435-4i linker
[1]
MDX-1435-3i
Monomethyl auristatin F
Microtubule (MT)
MDX-1435-3i linker
[1]
MDX-1435-6e
Monomethyl auristatin E
Microtubule (MT)
MDX-1435-6e linker
[1]
MDX-1435-amanitin
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
MDX-1435-amanitin linker
[1]
Obexelimab
ADC Info ADC Name Payload Target Linker Ref
Obexelimab-2i
Monomethyl auristatin F
Microtubule (MT)
Obexelimab-2i linker
[1]
Obexelimab-4i
Monomethyl auristatin F
Microtubule (MT)
Obexelimab-4i linker
[1]
Obexelimab-3i
Monomethyl auristatin F
Microtubule (MT)
Obexelimab-3i linker
[1]
Obexelimab-6e
Monomethyl auristatin E
Microtubule (MT)
Obexelimab-6e linker
[1]
Obexelimab-amanitin
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Obexelimab-amanitin linker
[1]
ADC Info ADC Name Payload Target Linker Ref
RC58-ADC-1
Dumycin-7
Human Deoxyribonucleic acid (hDNA)
Bis-bromine linker-PEG4-Asn-Ala-ethylenediamine
[12]
RC58-ADC-3
Duostain 3
Undisclosed
Bis-bromine linker-mono-glycine-PEG12-PAB
[12]
RC58-ADC-2
Duostain 3
Undisclosed
Bis-bromine linker-PEG2-VC-PAB
[12]
Tafasitamab
ADC Info ADC Name Payload Target Linker Ref
Tafasitamab-2i
Monomethyl auristatin F
Microtubule (MT)
Tafasitamab-2i linker
[1]
Tafasitamab-4i
Monomethyl auristatin F
Microtubule (MT)
Tafasitamab-4i linker
[1]
Tafasitamab-3i
Monomethyl auristatin F
Microtubule (MT)
Tafasitamab-3i linker
[1]
Tafasitamab-6e
Monomethyl auristatin E
Microtubule (MT)
Tafasitamab-6e linker
[1]
Tafasitamab-amanitin
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Tafasitamab-amanitin linker
[1]
Undisclosed
ADC Info ADC Name Payload Target Linker Ref
IKS-03
Undisclosed
Undisclosed
Undisclosed
[13]
LCB-73
Undisclosed
Undisclosed
Undisclosed
[14]
HuB4-DGN462
DGN462
Human Deoxyribonucleic acid (hDNA)
Sulfo-SPDB
[15]
CD19-ATAC
HDP 30.2115
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Mal-Val-Ala-PAB
[16]
NI-2201
Undisclosed
Undisclosed
Undisclosed
[17]
Anti-B4 monoclonal antibody-DC1 conjugate
DC1
Human Deoxyribonucleic acid (hDNA)
Undisclosed
[18]
NV102
Doxorubicin
DNA topoisomerase 2-alpha (TOP2A)
Undisclosed
[19]
CO-1008
Undisclosed
Undisclosed
Undisclosed
[20]
Denintuzumab mafodotin
Monomethyl auristatin F
Microtubule (MT)
Maleimido-caproyl
[21]
TE-1522
Undisclosed
Undisclosed
Undisclosed
[22]
Anti-CD19 monoclonal antibody-liposomal sodium butyrate conjugate
Sodium butyrate
Histone deacetylase 1 (HDAC1)
Undisclosed
[23]
B cell High Density Microparticles
Undisclosed
Undisclosed
Undisclosed
[24]
Monoclonal antibody B43-genistein-conjugate
Genistein
Pro-epidermal growth factor (EGF)
Undisclosed
[25]
Tissue/Disease specific Abundances of This Antigen
Tissue specific Abundances of This Antigen
ICD Disease Classification 01
Click to Show/Hide the 1 Disease of This Class
Bacterial infection [ICD-11: 1A00-1C4Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Gingival
The Specific Disease Bacterial infection of gingival
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 7.16E-25; Fold-change: 1.410147221; Z-score: 2.228067582
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 02
Click to Show/Hide the 22 Disease of This Class
Brain cancer [ICD-11: 2A00]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Brainstem
The Specific Disease Glioma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.293573004; Fold-change: -0.226021531; Z-score: -1.290021358
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue White matter
The Specific Disease Glioma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.000258934; Fold-change: -0.608737311; Z-score: -1.438800272
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Brainstem
The Specific Disease Neuroectodermal tumor
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.002467981; Fold-change: -1.046382672; Z-score: -1.693610121
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Nervous
The Specific Disease Brain cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 3.99E-06; Fold-change: -0.06162536; Z-score: -0.18087815
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Chronic myeloid leukemia [ICD-11: 2A20]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Polycythemia vera
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 4.09E-06; Fold-change: -0.343323727; Z-score: -1.41808629
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Whole blood
The Specific Disease Myelofibrosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.002728065; Fold-change: -0.542599714; Z-score: -2.179433787
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
MyeloDysplastic syndromes [ICD-11: 2A37]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Bone marrow
The Specific Disease Myelodysplastic syndromes
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 6.74E-16; Fold-change: -2.029114238; Z-score: -3.154547976
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.103656715; Fold-change: -1.872357634; Z-score: -1.393804248
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Lymphoma [ICD-11: 2A90- 2A85]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Tonsil
The Specific Disease Lymphoma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.597531584; Fold-change: 0.047577441; Z-score: 0.132440793
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Gastric cancer [ICD-11: 2B72]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Gastric
The Specific Disease Gastric cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.35676261; Fold-change: -0.647084127; Z-score: -0.760166801
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.016729513; Fold-change: -0.99175493; Z-score: -0.787439603
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Colon cancer [ICD-11: 2B90]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Colon
The Specific Disease Colon cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 1.09E-27; Fold-change: -0.772796476; Z-score: -1.01995821
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 4.47E-12; Fold-change: -0.477047033; Z-score: -0.601726604
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Pancreatic cancer [ICD-11: 2C10]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Pancreas
The Specific Disease Pancreatic cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.542182361; Fold-change: 0.081496426; Z-score: 0.044171098
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.14099629; Fold-change: -0.139788941; Z-score: -0.106042092
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Liver cancer [ICD-11: 2C12]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Liver
The Specific Disease Liver cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.177967209; Fold-change: -0.21540781; Z-score: -0.693039757
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.003655998; Fold-change: -0.150391206; Z-score: -0.349341419
The Expression Level of Disease Section Compare with the Other Disease Section p-value: 0.980096618; Fold-change: -0.040088022; Z-score: -0.168969846
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Lung cancer [ICD-11: 2C25]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Lung
The Specific Disease Lung cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 8.00E-21; Fold-change: 0.617730858; Z-score: 0.869906041
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 4.07E-16; Fold-change: 0.487655803; Z-score: 0.718725508
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Melanoma [ICD-11: 2C30]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Skin
The Specific Disease Melanoma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.005519727; Fold-change: 0.518951495; Z-score: 0.700209979
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Sarcoma [ICD-11: 2C35]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Muscle
The Specific Disease Sarcoma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 3.72E-29; Fold-change: -0.362071583; Z-score: -1.278107683
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.038138187; Fold-change: -0.596862307; Z-score: -2.325438952
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Breast cancer [ICD-11: 2C60]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Breast
The Specific Disease Breast cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 6.86E-38; Fold-change: 0.268944309; Z-score: 0.723584436
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.016287387; Fold-change: 0.046542313; Z-score: 0.084502389
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Ovarian cancer [ICD-11: 2C73]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Ovarian
The Specific Disease Ovarian cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.863374041; Fold-change: 0.000213001; Z-score: 0.000876527
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.000430241; Fold-change: 0.236464292; Z-score: 0.918868947
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Cervical cancer [ICD-11: 2C77]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Cervical
The Specific Disease Cervical cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.125139618; Fold-change: 0.107389446; Z-score: 0.342270949
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Uterine cancer [ICD-11: 2C78]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Endometrium
The Specific Disease Uterine cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 2.32E-05; Fold-change: 0.082716018; Z-score: 0.224919992
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.018240837; Fold-change: 0.585182031; Z-score: 1.366454093
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Prostate cancer [ICD-11: 2C82]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Prostate
The Specific Disease Prostate cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.000643964; Fold-change: -0.840331812; Z-score: -0.820421863
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Bladder cancer [ICD-11: 2C94]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Bladder
The Specific Disease Bladder cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.031512276; Fold-change: 0.357477486; Z-score: 0.740050348
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Retina cancer [ICD-11: 2D02]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Uvea
The Specific Disease Retinoblastoma tumor
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.567686869; Fold-change: -0.422983557; Z-score: -2.53900995
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Thyroid cancer [ICD-11: 2D10]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Thyroid
The Specific Disease Thyroid cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.018221177; Fold-change: 0.030367127; Z-score: 0.017986172
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.684669247; Fold-change: 0.064745747; Z-score: 0.055214027
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Adrenal cancer [ICD-11: 2D11]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Adrenal cortex
The Specific Disease Adrenocortical carcinoma
The Expression Level of Disease Section Compare with the Other Disease Section p-value: 0.074839655; Fold-change: -0.121720122; Z-score: -0.75919934
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Head and neck cancer [ICD-11: 2D42]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Head and neck
The Specific Disease Head and neck cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.631008965; Fold-change: 0.140762475; Z-score: 0.105447589
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Pituitary cancer [ICD-11: 2F37]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Pituitary
The Specific Disease Pituitary gonadotrope tumor
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.172801108; Fold-change: 0.142846221; Z-score: 0.588452776
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Pituitary
The Specific Disease Pituitary cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.036142011; Fold-change: 0.1391758; Z-score: 0.44683408
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 03
Click to Show/Hide the 1 Disease of This Class
Thrombocytopenia [ICD-11: 3B64]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Thrombocytopenia
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.44559903; Fold-change: 0.727544422; Z-score: 0.495745543
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 04
Click to Show/Hide the 2 Disease of This Class
Lupus erythematosus [ICD-11: 4A40]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Lupus erythematosus
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.021959257; Fold-change: -0.280993795; Z-score: -0.223740041
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Autoimmune disease [ICD-11: 4A4Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral monocyte
The Specific Disease Autoimmune uveitis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.849165417; Fold-change: 0.009913974; Z-score: 0.077679582
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 05
Click to Show/Hide the 1 Disease of This Class
Hyperlipoproteinaemia [ICD-11: 5C80]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Familial hypercholesterolemia
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.000212844; Fold-change: -0.758172162; Z-score: -1.43849846
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 06
Click to Show/Hide the 1 Disease of This Class
Schizophrenia [ICD-11: 6A20]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Superior temporal cortex
The Specific Disease Schizophrenia
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.798444383; Fold-change: -0.007052483; Z-score: -0.032304068
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 08
Click to Show/Hide the 3 Disease of This Class
Multiple sclerosis [ICD-11: 8A40]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Spinal cord
The Specific Disease Multiple sclerosis
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.460708469; Fold-change: 0.082345968; Z-score: 0.793464718
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Plasmacytoid dendritic cells
The Specific Disease Multiple sclerosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.330847637; Fold-change: -0.107639501; Z-score: -0.185123903
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Epilepsy [ICD-11: 8A60]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peritumoral cortex
The Specific Disease Epilepsy
The Expression Level of Disease Section Compare with the Other Disease Section p-value: 0.302687519; Fold-change: -0.03575179; Z-score: -0.177501537
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Cerebral ischaemic stroke [ICD-11: 8B11]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Cardioembolic Stroke
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 4.87E-09; Fold-change: -1.202761109; Z-score: -2.014806056
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Peripheral blood
The Specific Disease Ischemic stroke
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.950168363; Fold-change: -0.33389947; Z-score: -0.432496316
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 1
Click to Show/Hide the 6 Disease of This Class
HIV [ICD-11: 1C60-1C62]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue White matter
The Specific Disease HIV
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.187793631; Fold-change: -0.026251958; Z-score: -0.091497819
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Influenza [ICD-11: 1E30]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Influenza
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.010508608; Fold-change: 0.78631082; Z-score: 4.103354421
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Chronic hepatitis C [ICD-11: 1E51.1]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Chronic hepatitis C
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.632975184; Fold-change: -0.347636404; Z-score: -0.468850856
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Sepsis [ICD-11: 1G40-1G41]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Sepsis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 4.58E-11; Fold-change: -0.790430064; Z-score: -1.124258106
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Septic shock [ICD-11: 1G41]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Septic shock
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 4.29E-29; Fold-change: -0.746671047; Z-score: -1.263006838
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Pediatric respiratory syncytial virus infection [ICD-11: CA40.11]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Pediatric respiratory syncytial virus infection
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.024137949; Fold-change: -0.350831575; Z-score: -0.735351427
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 11
Click to Show/Hide the 6 Disease of This Class
Essential hypertension [ICD-11: BA00]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Essential hypertension
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.261228119; Fold-change: -1.054481209; Z-score: -10.54689768
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Myocardial infarction [ICD-11: BA41]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Myocardial infarction
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.844663494; Fold-change: 0.056164438; Z-score: 0.064037889
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Coronary artery disease [ICD-11: BA8Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Coronary artery disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.200945483; Fold-change: -0.558090581; Z-score: -0.599421927
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Aortic stenosis [ICD-11: BB70]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Calcified aortic valve
The Specific Disease Aortic stenosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.149694747; Fold-change: 0.087459823; Z-score: 0.578139416
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Arteriosclerosis [ICD-11: BD40]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Arteriosclerosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.205250995; Fold-change: -0.255802212; Z-score: -0.701870618
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Aneurysm [ICD-11: BD50]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Intracranial artery
The Specific Disease Aneurysm
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.255524704; Fold-change: 0.218279118; Z-score: 0.701359308
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 12
Click to Show/Hide the 8 Disease of This Class
Immunodeficiency [ICD-11: 4A00-4A20]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Immunodeficiency
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.219754714; Fold-change: 0.028692585; Z-score: 0.346913397
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Apnea [ICD-11: 7A40]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Hyperplastic tonsil
The Specific Disease Apnea
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.153197207; Fold-change: 2.635954591; Z-score: 7.589246911
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Olive pollen allergy [ICD-11: CA08.00]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Olive pollen allergy
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.529858726; Fold-change: -0.460972039; Z-score: -0.928468608
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Chronic rhinosinusitis [ICD-11: CA0A]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Sinus mucosa
The Specific Disease Chronic rhinosinusitis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.156561014; Fold-change: 0.199657374; Z-score: 1.512898194
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Chronic obstructive pulmonary disease [ICD-11: CA22]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Lung
The Specific Disease Chronic obstructive pulmonary disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.741936726; Fold-change: 0.090273878; Z-score: 0.166244675
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Small airway epithelium
The Specific Disease Chronic obstructive pulmonary disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.520452716; Fold-change: 0.032009978; Z-score: 0.136440017
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Asthma [ICD-11: CA23]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Nasal and bronchial airway
The Specific Disease Asthma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.049596063; Fold-change: 0.166926113; Z-score: 0.179644725
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Human rhinovirus infection [ICD-11: CA42]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Nasal Epithelium
The Specific Disease Human rhinovirus infection
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.466133351; Fold-change: -0.140115629; Z-score: -0.306750224
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Idiopathic pulmonary fibrosis [ICD-11: CB03.4]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Lung
The Specific Disease Idiopathic pulmonary fibrosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.014384669; Fold-change: 0.289016178; Z-score: 1.340521578
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 13
Click to Show/Hide the 5 Disease of This Class
Periodontal disease [ICD-11: DA0C]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Gingival
The Specific Disease Periodontal disease
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 1.31E-19; Fold-change: 1.256173632; Z-score: 1.99635053
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Eosinophilic gastritis [ICD-11: DA42.2]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Gastric antrum
The Specific Disease Eosinophilic gastritis
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.225972021; Fold-change: 0.146139245; Z-score: 0.828675724
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Liver failure [ICD-11: DB99.7-DB99.8]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Liver
The Specific Disease Liver failure
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 1.37E-05; Fold-change: 1.163260039; Z-score: 2.855390447
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Ulcerative colitis [ICD-11: DD71]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Colon mucosal
The Specific Disease Ulcerative colitis
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 7.85E-07; Fold-change: 0.941311897; Z-score: 2.017070851
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Irritable bowel syndrome [ICD-11: DD91.0]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Rectal colon
The Specific Disease Irritable bowel syndrome
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.100570905; Fold-change: 0.083680268; Z-score: 0.099594296
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 14
Click to Show/Hide the 5 Disease of This Class
Atopic dermatitis [ICD-11: EA80]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Skin
The Specific Disease Atopic dermatitis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.000175039; Fold-change: 0.14314738; Z-score: 0.807939772
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Psoriasis [ICD-11: EA90]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Skin
The Specific Disease Psoriasis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 5.13E-11; Fold-change: -0.366465387; Z-score: -0.814733281
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 6.93E-47; Fold-change: 0.950053141; Z-score: 4.350653401
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Vitiligo [ICD-11: ED63.0]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Skin
The Specific Disease Vitiligo
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.054711153; Fold-change: -0.210765078; Z-score: -1.337694455
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Alopecia [ICD-11: ED70]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Skin from scalp
The Specific Disease Alopecia
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.019224825; Fold-change: 0.148908678; Z-score: 0.465552236
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Sensitive skin [ICD-11: EK0Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Skin
The Specific Disease Sensitive skin
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.561991309; Fold-change: -0.052672575; Z-score: -0.505945982
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 15
Click to Show/Hide the 6 Disease of This Class
Osteoarthritis [ICD-11: FA00-FA0Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Synovial
The Specific Disease Osteoarthritis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.387810634; Fold-change: 0.27729675; Z-score: 1.059911864
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Arthropathy [ICD-11: FA00-FA5Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Arthropathy
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.648829517; Fold-change: -0.163947961; Z-score: -0.360892597
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Arthritis [ICD-11: FA20]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Arthritis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.000964258; Fold-change: -0.547763174; Z-score: -0.764909816
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Rheumatoid arthritis [ICD-11: FA20]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Synovial
The Specific Disease Rheumatoid arthritis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.002878413; Fold-change: 0.427047639; Z-score: 1.495429157
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Ankylosing spondylitis [ICD-11: FA92.0Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Pheripheral blood
The Specific Disease Ankylosing spondylitis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.656121196; Fold-change: -0.071303866; Z-score: -0.347040994
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Osteoporosis [ICD-11: FB83]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Bone marrow
The Specific Disease Osteoporosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.23620727; Fold-change: 0.145547186; Z-score: 1.589141961
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 16
Click to Show/Hide the 2 Disease of This Class
Endometriosis [ICD-11: GA10]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Endometrium
The Specific Disease Endometriosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.001386995; Fold-change: 0.216908021; Z-score: 0.780090592
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Interstitial cystitis [ICD-11: GC00.3]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Bladder
The Specific Disease Interstitial cystitis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 7.97E-06; Fold-change: 2.942662131; Z-score: 4.981091248
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 19
Click to Show/Hide the 1 Disease of This Class
Preterm birth [ICD-11: KA21.4Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Myometrium
The Specific Disease Preterm birth
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.985559691; Fold-change: -0.07000865; Z-score: -0.464279952
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 2
Click to Show/Hide the 8 Disease of This Class
Acute myelocytic leukemia [ICD-11: 2A60]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Bone marrow
The Specific Disease Acute myelocytic leukemia
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 2.33E-24; Fold-change: -1.060235455; Z-score: -1.328624264
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Myeloma [ICD-11: 2A83]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Bone marrow
The Specific Disease Myeloma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 2.33E-07; Fold-change: -1.903622593; Z-score: -6.638832944
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Peripheral blood
The Specific Disease Myeloma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.769255144; Fold-change: -0.064173239; Z-score: -0.492409928
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Oral cancer [ICD-11: 2B6E]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Oral
The Specific Disease Oral cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.10880601; Fold-change: -0.17621574; Z-score: -0.161392812
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.001971873; Fold-change: -0.286337053; Z-score: -0.465272225
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Esophagal cancer [ICD-11: 2B70]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Esophagus
The Specific Disease Esophagal cancer
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.0321341; Fold-change: -1.054852221; Z-score: -1.726404061
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Rectal cancer [ICD-11: 2B92]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Rectal colon
The Specific Disease Rectal cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.053092761; Fold-change: -0.425775827; Z-score: -0.784271069
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.010037528; Fold-change: -0.702635773; Z-score: -1.536322361
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Skin cancer [ICD-11: 2C30-2C3Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Skin
The Specific Disease Skin cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.030733062; Fold-change: -0.074759144; Z-score: -0.144028895
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 9.43E-44; Fold-change: 1.059179166; Z-score: 2.076173698
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Renal cancer [ICD-11: 2C90-2C91]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Kidney
The Specific Disease Renal cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.00127383; Fold-change: -0.470668701; Z-score: -1.818670547
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 2.53E-06; Fold-change: -0.54615426; Z-score: -1.113810358
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Ureter cancer [ICD-11: 2C92]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Urothelium
The Specific Disease Ureter cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.17265883; Fold-change: -0.051406948; Z-score: -0.187640742
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 20
Click to Show/Hide the 2 Disease of This Class
Simpson golabi behmel syndrome [ICD-11: LD2C]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Adipose
The Specific Disease Simpson golabi behmel syndrome
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.031836224; Fold-change: 0.25959497; Z-score: 2.416902672
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Tuberous sclerosis complex [ICD-11: LD2D.2]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Perituberal
The Specific Disease Tuberous sclerosis complex
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.106084597; Fold-change: 0.313503327; Z-score: 1.170497322
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 3
Click to Show/Hide the 3 Disease of This Class
Anemia [ICD-11: 3A00-3A9Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Bone marrow
The Specific Disease Anemia
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.029467644; Fold-change: -1.215320629; Z-score: -1.360636451
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Sickle cell disease [ICD-11: 3A51.0-3A51.3]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Sickle cell disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.064895305; Fold-change: 0.169353682; Z-score: 0.401719603
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Thrombocythemia [ICD-11: 3B63]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Thrombocythemia
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.393586267; Fold-change: 0.042927355; Z-score: 0.178131279
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 4
Click to Show/Hide the 4 Disease of This Class
Scleroderma [ICD-11: 4A42.Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Scleroderma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 9.92E-06; Fold-change: -1.221193588; Z-score: -2.647070825
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Sjogren syndrome [ICD-11: 4A43]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Salivary gland
The Specific Disease Sjogren syndrome
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.973418287; Fold-change: -0.305795082; Z-score: -0.718821281
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.472074041; Fold-change: 0.001470757; Z-score: 0.00429712
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Behcet disease [ICD-11: 4A62]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Behcet disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.237639419; Fold-change: -0.380216791; Z-score: -0.68393196
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Autosomal dominant monocytopenia [ICD-11: 4B04]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Autosomal dominant monocytopenia
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.97312428; Fold-change: -0.014543534; Z-score: -0.050524802
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 5
Click to Show/Hide the 5 Disease of This Class
Type 2 diabetes [ICD-11: 5A11]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Liver
The Specific Disease Type 2 diabetes
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.010689341; Fold-change: -0.162202779; Z-score: -1.38390897
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Polycystic ovary syndrome [ICD-11: 5A80.1]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Vastus lateralis muscle
The Specific Disease Polycystic ovary syndrome
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.212762766; Fold-change: 0.085840461; Z-score: 0.858272868
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Obesity [ICD-11: 5B81]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Subcutaneous Adipose
The Specific Disease Obesity
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.984325688; Fold-change: -0.048450065; Z-score: -0.200569127
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Pompe disease [ICD-11: 5C51.3]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Biceps muscle
The Specific Disease Pompe disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.994712465; Fold-change: -0.002854789; Z-score: -0.02053996
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Batten disease [ICD-11: 5C56.1]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Batten disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.668725266; Fold-change: 0.4919918; Z-score: 0.978187271
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 6
Click to Show/Hide the 2 Disease of This Class
Autism [ICD-11: 6A02]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Autism
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.670266727; Fold-change: 0.075676469; Z-score: 0.189895766
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Anxiety disorder [ICD-11: 6B00-6B0Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Anxiety disorder
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.060500552; Fold-change: -0.238045973; Z-score: -0.352929582
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 8
Click to Show/Hide the 7 Disease of This Class
Parkinson disease [ICD-11: 8A00]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Substantia nigra
The Specific Disease Parkinson disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.934625426; Fold-change: 0.039980775; Z-score: 0.189953988
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Huntington disease [ICD-11: 8A01]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Huntington disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.387594552; Fold-change: 0.045250742; Z-score: 0.065909399
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Alzheimer disease [ICD-11: 8A20]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Entorhinal cortex
The Specific Disease Alzheimer disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.165107387; Fold-change: 0.026740908; Z-score: 0.15034813
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Seizure [ICD-11: 8A60-8A6Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Seizure
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.87089754; Fold-change: 0.031386688; Z-score: 0.032399444
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Lateral sclerosis [ICD-11: 8B60.4]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Skin
The Specific Disease Lateral sclerosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.602509835; Fold-change: 0.026374548; Z-score: 0.136984142
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Cervical spinal cord
The Specific Disease Lateral sclerosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.115374274; Fold-change: 0.154889127; Z-score: 0.975822215
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Muscular atrophy [ICD-11: 8C70]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Muscle
The Specific Disease Muscular atrophy
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.241314292; Fold-change: 0.024464764; Z-score: 0.082565212
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Myopathy [ICD-11: 8C70.6]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Muscle
The Specific Disease Myopathy
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.995986682; Fold-change: -0.110648502; Z-score: -0.402953848
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
References
Ref 1 Compositions and methods related to anti-cd19 antibody drug conjugates; 2017-03-30.
Ref 2 A First-in-Human Phase 1 Study of Abbv-319, an Antibody-Drug Conjugate Composed of a CD19 Antibody Linked to a Potent Proprietary Glucocorticoid Receptor Modulator, in Patients with Relapsed or Refractory B-Cell Malignancies. Blood (2022) 140 (Supplement 1): 3746-3747. doi: 10.1182/blood-2022-166809.
Ref 3 Synthesis and biological evaluation of antibody conjugates of phosphate prodrugs of cytotoxic DNA alkylators for the targeted treatment of cancer. J Med Chem. 2012 Jan 26;55(2):766-82.
Ref 4 Antibody-drug conjugates comprising branched linkers and methods related thereto; 2017-06-01.
Ref 5 Conjugates comprising self-immolative groups and methods related thereto.
Ref 6 Introduction to basic information on ADC drug hA19-SN-38 antibody-drug conjugate - Immunomedics.
Ref 7 A coiled-coil masking domain for selective activation of therapeutic antibodies. Nat Biotechnol. 2019 Jul;37(7):761-765. doi: 10.1038/s41587-019-0135-x. Epub 2019 May 27.
Ref 8 Therapeutic potential of SGN-CD19B, a PBD-based anti-CD19 drug conjugate, for treatment of B-cell malignancies. Blood. 2017 Nov 2;130(18):2018-2026. doi: 10.1182/blood-2017-04-779389. Epub 2017 Sep 13.
Ref 9 A phase II, single-arm, multicentre study of coltuximab ravtansine (SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma. Br J Haematol. 2016 Jun;173(5):722-30. doi: 10.1111/bjh.13992.
Ref 10 Hydrophilic antibody-drug conjugates; 2015-08-20.
Ref 11 A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma. Clin Cancer Res. 2019 Dec 1;25(23):6986-6994.
Ref 12 Development of novel anti-CD19 antibody-drug conjugates for B-cell lymphoma treatment. Int Immunopharmacol. 2018 Sep;62:299-308. doi: 10.1016/j.intimp.2018.06.034. Epub 2018 Jul 23.
Ref 13 IKS03, a Next Generation CD19-Targeted Antibody Drug Conjugate, Shows Potent Activity in Preclinical Models of Aggressive B-Cell Lymphomas. Blood (2022) 140 (Supplement 1): 31343135.
Ref 14 LegoChem Biosciences and Iksuda enter Licensing Agreement for Antibody Drug Conjugate program; 27 Jan 2021.
Ref 15 The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia models. Haematologica. 2019 Aug;104(8):1633-1639. doi: 10.3324/haematol.2018.211011. Epub 2019 Feb 7.
Ref 16 CD19 - a potential target for Amanitin-based ADCs. Cancer Res (2017) 77 (13_Supplement): 62.
Ref 17 Lightchain biosciences biotechnology company product pipeline
Ref 18 Introduction to basic information on anti-B4 monoclonal antibody-DC1 conjugate (Anti-B4-DC1).
Ref 19 ADC review: basic information about NV102 (Doxorubicin-Anti-CD19).
Ref 20 Progression towards the clinic by 2025 with a strategy for rapid FIH data acquisition.
Ref 21 Preclinical activity of the antibody-drug conjugate denintuzumab mafodotin (SGN-CD19A) against pediatric acute lymphoblastic leukemia xenografts. Pediatr Blood Cancer. 2019 Aug;66(8):e27765. doi: 10.1002/pbc.27765. Epub 2019 Apr 23.
Ref 22 Introduction to basic information on ADC drug TE-1522.
Ref 23 Effect of liposomes containing sodium butyrate conjugated with anti-CD19 monoclonal antibody on in vitro and in vivo growth of malignant lymphoma. Cancer Res. 1990 Jun 1;50(11):3245-8.
Ref 24 Effective purging of autologous hematopoietic stem cells using anti-B-cell monoclonal antibody-coated high-density microparticles prior to high-dose therapy for patients with non-Hodgkin's lymphoma. Biol Blood Marrow Transplant. 2002;8(8):429-34. doi: 10.1053/bbmt.2002.v8.pm12234168.
Ref 25 Introduction to basic information on ADC drug monoclonal antibody B43 Genistein-conjugate.

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.